Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 6 | 2017 | 420 | 1.630 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2026 | 26 | 0.960 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2026 | 18 | 0.960 |
Why?
|
| Receptor, Notch1 | 1 | 2026 | 78 | 0.930 |
Why?
|
| Peritoneal Neoplasms | 2 | 2016 | 47 | 0.890 |
Why?
|
| Biomarkers, Tumor | 8 | 2019 | 1586 | 0.890 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2026 | 248 | 0.860 |
Why?
|
| Carcinoma, Ductal | 2 | 2026 | 15 | 0.810 |
Why?
|
| Papillomavirus Infections | 1 | 2026 | 394 | 0.690 |
Why?
|
| Salivary Gland Neoplasms | 2 | 2019 | 63 | 0.680 |
Why?
|
| Glioma | 2 | 2016 | 494 | 0.670 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2026 | 750 | 0.640 |
Why?
|
| Immunohistochemistry | 8 | 2019 | 1591 | 0.560 |
Why?
|
| Carcinoma | 2 | 2019 | 291 | 0.530 |
Why?
|
| V-Set Domain-Containing T-Cell Activation Inhibitor 1 | 1 | 2016 | 1 | 0.490 |
Why?
|
| Neurocytoma | 1 | 2016 | 1 | 0.490 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 9 | 0.490 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2016 | 17 | 0.470 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2016 | 11 | 0.470 |
Why?
|
| Paired Box Transcription Factors | 1 | 2016 | 72 | 0.470 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2016 | 269 | 0.460 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2016 | 33 | 0.460 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2015 | 92 | 0.430 |
Why?
|
| Endometrial Neoplasms | 1 | 2016 | 110 | 0.430 |
Why?
|
| Teratoma | 1 | 2015 | 120 | 0.420 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2016 | 223 | 0.400 |
Why?
|
| Receptor, Insulin | 2 | 2009 | 65 | 0.380 |
Why?
|
| Kidney Neoplasms | 1 | 2016 | 421 | 0.340 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2026 | 236 | 0.330 |
Why?
|
| Insulin-Like Growth Factor II | 2 | 2009 | 40 | 0.330 |
Why?
|
| Liver Glycogen | 1 | 2009 | 20 | 0.310 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 972 | 0.280 |
Why?
|
| Iodoacetic Acid | 1 | 2008 | 3 | 0.280 |
Why?
|
| Hepatocytes | 1 | 2009 | 232 | 0.270 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2008 | 37 | 0.270 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2017 | 41 | 0.250 |
Why?
|
| Parotid Neoplasms | 1 | 2026 | 21 | 0.240 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2026 | 70 | 0.230 |
Why?
|
| Retina | 1 | 2008 | 425 | 0.210 |
Why?
|
| Insulin | 1 | 2009 | 1149 | 0.210 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 555 | 0.200 |
Why?
|
| Chimera | 1 | 2002 | 79 | 0.190 |
Why?
|
| Neoplasm Proteins | 1 | 2026 | 680 | 0.180 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 6797 | 0.170 |
Why?
|
| Adult | 6 | 2018 | 31282 | 0.170 |
Why?
|
| Aged | 6 | 2018 | 21025 | 0.150 |
Why?
|
| Female | 12 | 2026 | 70963 | 0.150 |
Why?
|
| Middle Aged | 5 | 2018 | 28601 | 0.150 |
Why?
|
| RNA | 1 | 2002 | 517 | 0.150 |
Why?
|
| Keratin-5 | 1 | 2018 | 9 | 0.140 |
Why?
|
| HMGA2 Protein | 1 | 2018 | 12 | 0.140 |
Why?
|
| Keratin-6 | 1 | 2018 | 14 | 0.140 |
Why?
|
| Humans | 15 | 2026 | 131163 | 0.140 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2019 | 743 | 0.140 |
Why?
|
| Estrogen Receptor beta | 1 | 2018 | 87 | 0.140 |
Why?
|
| Young Adult | 3 | 2016 | 10103 | 0.130 |
Why?
|
| Transcription Factors | 1 | 2007 | 2406 | 0.130 |
Why?
|
| DNA | 1 | 2002 | 1399 | 0.130 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 252 | 0.130 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2017 | 50 | 0.120 |
Why?
|
| Dirofilariasis | 1 | 2016 | 5 | 0.120 |
Why?
|
| Cheek | 1 | 2016 | 22 | 0.120 |
Why?
|
| Mouth Diseases | 1 | 2016 | 16 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 116 | 0.120 |
Why?
|
| PAX8 Transcription Factor | 1 | 2016 | 15 | 0.120 |
Why?
|
| Receptors, Androgen | 1 | 2018 | 408 | 0.110 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2015 | 30 | 0.110 |
Why?
|
| Neoplasm Grading | 1 | 2016 | 274 | 0.110 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2015 | 37 | 0.110 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 775 | 0.100 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 905 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 386 | 0.100 |
Why?
|
| Hysterectomy | 1 | 2015 | 202 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 1071 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 1207 | 0.100 |
Why?
|
| Neoadjuvant Therapy | 1 | 2015 | 400 | 0.100 |
Why?
|
| Time Factors | 2 | 2016 | 6196 | 0.090 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 1410 | 0.090 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 1287 | 0.090 |
Why?
|
| Immunotherapy | 1 | 2016 | 768 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 1939 | 0.080 |
Why?
|
| Glycogen Synthase | 1 | 2009 | 8 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2016 | 1077 | 0.080 |
Why?
|
| Crosses, Genetic | 1 | 2009 | 152 | 0.080 |
Why?
|
| Glycogen | 1 | 2009 | 50 | 0.070 |
Why?
|
| DNA Primers | 1 | 2009 | 599 | 0.070 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2009 | 93 | 0.070 |
Why?
|
| RNA, Untranslated | 1 | 2009 | 109 | 0.070 |
Why?
|
| Calbindins | 1 | 2008 | 18 | 0.070 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2008 | 22 | 0.070 |
Why?
|
| Retinal Horizontal Cells | 1 | 2008 | 12 | 0.070 |
Why?
|
| Protein Kinase C-alpha | 1 | 2008 | 20 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 239 | 0.070 |
Why?
|
| Retinal Bipolar Cells | 1 | 2008 | 42 | 0.070 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2008 | 102 | 0.070 |
Why?
|
| Adolescent | 2 | 2016 | 20987 | 0.060 |
Why?
|
| Heterozygote | 1 | 2009 | 737 | 0.060 |
Why?
|
| Rabbits | 1 | 2008 | 575 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 128 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 2602 | 0.060 |
Why?
|
| Microphthalmos | 1 | 2007 | 54 | 0.060 |
Why?
|
| Fetus | 1 | 2009 | 568 | 0.060 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2026 | 65 | 0.060 |
Why?
|
| Cell Survival | 1 | 2008 | 826 | 0.060 |
Why?
|
| Homeostasis | 1 | 2009 | 712 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2008 | 556 | 0.060 |
Why?
|
| Child | 2 | 2016 | 26341 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2009 | 3819 | 0.050 |
Why?
|
| Placenta | 1 | 2009 | 504 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2009 | 2885 | 0.050 |
Why?
|
| Animals | 4 | 2009 | 33912 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2009 | 2550 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2016 | 12936 | 0.050 |
Why?
|
| Mice | 3 | 2009 | 18301 | 0.050 |
Why?
|
| Male | 4 | 2018 | 64957 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2026 | 1075 | 0.040 |
Why?
|
| Receptor, trkC | 1 | 2019 | 13 | 0.040 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2019 | 6 | 0.040 |
Why?
|
| Salivary Glands | 1 | 2019 | 35 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2015 | 15110 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2019 | 58 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2026 | 1590 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2002 | 713 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2017 | 58 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2019 | 760 | 0.030 |
Why?
|
| Mutation | 1 | 2007 | 6099 | 0.020 |
Why?
|
| Phenotype | 2 | 2015 | 4497 | 0.020 |
Why?
|
| Biopsy | 1 | 2015 | 1239 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 1882 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2304 | 0.020 |
Why?
|
| Placentation | 1 | 2009 | 59 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 212 | 0.020 |
Why?
|
| Organ Size | 1 | 2009 | 407 | 0.020 |
Why?
|
| RNA, Long Noncoding | 1 | 2009 | 218 | 0.020 |
Why?
|
| Pregnancy | 1 | 2009 | 7512 | 0.010 |
Why?
|